, the COA report said that these hospitals are marking up oncology drugs at rates that are "problematic" because they result in much higher costs than drugs in community oncology practices. (Photo: Shutterstock)
A report finding that safety-net hospitals are charging 3.8 times more than the purchase price for oncology drugs has sparked pushback from hospitals, which say the report had too small a sample size and did not accurately reflect costs to consumers.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
